£650K
The investment round was led by Angels in MedCity and Angel Academe.
Beamline Diagnostics develops a rapid point-of-care biopsy screening system.
Beamline Diagnostics develops a rapid biopsy triaging system that screens tissue samples at the point of care. The technology aims to reduce unnecessary pathology lab workloads.
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from Beamline Diagnostics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Liberty Foreman
CEO
Katherine Willetts
Ian Smith
Chairman
The investment round was led by Angels in MedCity and Angel Academe.